DFX Intelligence

Data Factory

RIA / WealthPrivate fundprivate equity fund3(c)(7)dropped

PHARMAKON OPPORTUNITIES LP

advised by PHARMAKON ADVISORS, LP

Delaware, United States

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:7ed3b60c-e76c-174b-53f4-2f43771c4711

Data as of Apr 12, 2019 (this record's last observation) from federal regulator filings. Page built Sep 21, 2026, 9:59 AM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 0
On other graphs: 1
Observed: Mar 29, 2019 to Apr 12, 2019
2 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Pharmakon Opportunities LP

Private equity fund · shared adv fund id

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Adviser: PHARMAKON ADVISORS, LPCRD 161150
Fund type: Private Equity Fund
Latest reported GAV: $46.5Mgross asset value on Schedule D 7.B(1), as of 2019-04-12; never fund size
Peak reported GAV: $46.5M
Beneficial owners: 12
Minimum investment: $0
Owned by the adviser: 0%
Owned by funds of funds: 0%
Owned by non-US persons: 0%
Clients solicited: no
Organised in: Delaware, United States
First reported: Mar 29, 2019
Last reported: Apr 12, 2019fund reporting on the SEC extract ends 2024-12-31
Filings reporting it: 2
Fund id: 805-8622676619

Reported gross asset value by filing

each Schedule D 7.B(1) row as filed; GAV is gross asset value, never fund size

Filed	GAV	Owners	Minimum	Adviser owns	Audited	Name as filed
Apr 12, 2019	$46.5M	12	$0	0.0%	yes	PHARMAKON OPPORTUNITIES LP
Mar 29, 2019	$46.5M	12	$0	0.0%	yes	PHARMAKON OPPORTUNITIES LP

Custodians

Schedule D 7.B(1) question 25, as filed

Custodian	Legal name	City	State	Country	Related person	SEC number
BANK OF AMERICA	BANK OF AMERICA	Dallas	Texas	United States	no	n/a

Relationships

Advises (1)

← PHARMAKON ADVISORS, LPRegistered adviserPrivate Equity Fund, IA, no longer reported
Mar 29, 2019 to Apr 12, 2019factForm ADV

Dated events

No dated event names this entity yet.

Provenance

Graph: RIA / Wealth Management
Canonical id: dfx:ria:7ed3b60c-e76c-174b-53f4-2f43771c4711
First observed: Mar 29, 2019
Last observed: Apr 12, 2019 90 months ago
Source families: Federal regulator filings
1 registered feed stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

PHARMAKON OPPORTUNITIES LP

advised by PHARMAKON ADVISORS, LP

Delaware, United States

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:7ed3b60c-e76c-174b-53f4-2f43771c4711

Data as of Apr 12, 2019 (this record's last observation) from federal regulator filings. Page built Sep 21, 2026, 9:59 AM UTC and rebuilt at most every 15 minutes.

Filed

GAV

Owners

Minimum

Adviser owns

Audited

Name as filed

Apr 12, 2019

$46.5M

0.0%

yes

PHARMAKON OPPORTUNITIES LP

Mar 29, 2019

$46.5M

0.0%

yes

PHARMAKON OPPORTUNITIES LP

Custodian

Legal name

City

State

Country

Related person

SEC number

BANK OF AMERICA

Dallas

Texas

United States

n/a